Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2017 | 4 | 0.73 | Why? |
| Uniparental Disomy | 1 | 2017 | 3 | 0.73 | Why? |
| Genomic Imprinting | 1 | 2017 | 7 | 0.73 | Why? |
| Blood Gas Analysis | 2 | 2017 | 893 | 0.26 | Why? |
| Atracurium | 1 | 2019 | 19 | 0.20 | Why? |
| Heparin | 2 | 2021 | 2600 | 0.18 | Why? |
| Neuromuscular Blocking Agents | 1 | 2019 | 121 | 0.18 | Why? |
| Personnel, Hospital | 2 | 2020 | 2273 | 0.16 | Why? |
| Fathers | 1 | 2017 | 114 | 0.16 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2017 | 9659 | 0.15 | Why? |
| Placebos | 1 | 2017 | 629 | 0.14 | Why? |
| North America | 1 | 2017 | 1400 | 0.12 | Why? |
| Positive-Pressure Respiration | 1 | 2019 | 1160 | 0.11 | Why? |
| Treatment Failure | 3 | 2021 | 2106 | 0.10 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.10 | Why? |
| Anticoagulants | 2 | 2021 | 9563 | 0.10 | Why? |
| Ventricular Dysfunction, Right | 1 | 2017 | 639 | 0.10 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.09 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.08 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.08 | Why? |
| Pilot Projects | 1 | 2017 | 5182 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.06 | Why? |
| Echocardiography | 1 | 2017 | 3661 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Hypoxia | 1 | 2017 | 3626 | 0.06 | Why? |
| United States | 7 | 2021 | 46150 | 0.06 | Why? |
| Male | 14 | 2021 | 367725 | 0.06 | Why? |
| Adult | 12 | 2021 | 244371 | 0.05 | Why? |
| Intensive Care Units | 2 | 2017 | 29594 | 0.05 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.05 | Why? |
| Neuromuscular Blockade | 1 | 2019 | 66 | 0.05 | Why? |
| Hemorrhage | 2 | 2021 | 3013 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Aged | 9 | 2021 | 215776 | 0.05 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.04 | Why? |
| Academic Medical Centers | 2 | 2020 | 3088 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2020 | 51949 | 0.04 | Why? |
| Conscious Sedation | 1 | 2019 | 222 | 0.04 | Why? |
| Single-Blind Method | 1 | 2020 | 1283 | 0.04 | Why? |
| Respiration, Artificial | 2 | 2021 | 22116 | 0.04 | Why? |
| Humans | 16 | 2021 | 930598 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.04 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2017 | 657 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Oximetry | 1 | 2017 | 658 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Hospital Mortality | 3 | 2021 | 22087 | 0.03 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2021 | 1731 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.02 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Heart Ventricles | 1 | 2017 | 1139 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Survival Analysis | 1 | 2021 | 7592 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Logistic Models | 1 | 2021 | 9089 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Pandemics | 5 | 2020 | 389249 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Risk Assessment | 1 | 2021 | 25439 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.00 | Why? |
Khan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(81)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(526)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_